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Abstract 
Diabetic individuals are more susceptible to infection than normal individuals. 
Infections of diabetics tend to be more severe and are more likely to have serious 
systemic complications. Porphyromonas gingivalis , an anaerobic Gram-negative 
bacterium , is associated with adult periodontitis and lesions of endodontic origin. 
Infections by P. gingivalis result in necrosis of soft tissues and the activation of 
inflammatory responses that lead to induction of osteoclastogenesis. Polymorphonuclear 
cells (PMNs) , components of the innate immune response, act as the primary leukocyte 
that counteracts bacterial infection. 
The objective of this study was to test the hypothesis that diabetes alters the 
inflammatory response to P. gingivalis. The host response to P. gingivalis in diabetic and 
matched control mice following injection with live P. gingivalis or P. gingivalis 
lipopolysaccharide (LPS) into the scalp was evaluated and the recruitment of PMNs and 
the necrosis of P. gingivalis infected tissue was assessed. 
Mice were sacrificed 1 day and 3 days after injection. On day 1, P. gingivalis 
induced areas of necrosis that were simi~ar in normal and diabetic mice (p>0.05 , 
Student ' s T test). On day 3, there were 3.35 PMN/field in the diabetic mice, which was 
55% greater than control mice, (2.17 PMN/field) , and was statistically significant 
(p<0.05). Similar results were obtained with P. gingivalis LPS. These results indicate 
that the initial responses to P. gingivalis are similar in normal and diabetic mice, but that 
there are prolonged inflammatory responses in diabetic mice . 
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Introduction 
Diabetic individuals are known to be more susceptible to common infections than 
normal individuals and are prone to have more severe infections and systemic 
complications. The increased incidence of severe infections for the diabetic can be the 
result of increased infection duration. 
This thesis reports the evaluation of some of the elements involved in an 
inflammatory response in normal and diabetic specimens. This was limited to examining 
diabetic and normal mice responses to inoculation with Porphyromonas gingivalis. The 
numbers of polymorphonuclear cells (PMNs) were recorded at the inoculation site of 
these mice at specific time intervals and were used as an indication of the severity and 
duration of the infection in the groups. 
Porphyromonas gingivalis is a Gram-negative anaerobic rod that is common in 
the oral flora and common in lesions of endodontic origin. This bacteria and its 
components , such as P. gingivalis LPS, is used to initiate the host response and elicit an 
infection so that the specimen ' s inflammatory response can be studied. One component 
of the host response is the innate immune response , which uses leukocytes. PMN s are 
components of the innate immune response and the principal leukocyte in clearing 
bacterial infection . Of the numerous ways the PMNs can clear infection , one includes 
releasing enzymes that generate superoxide radicals and lysozymes. In addition to 
destroying unwanted bacteria , the PMN s destroy healthy tissue in the area . 
This study used Porphyromonas gingivalis and its component P. gingivalis LPS 
to elicit the innate immune response . Evaluating the recruitment of PMNs to the 
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inoculation site and examining the necrotic tissue in the area of infected tissue 
determined the host response. 
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Literature Review 
Review of Inflammation 
Inflammation is typically defined as a defense mechanism of higher animals 
against an injurious stimulus [ 1]. Irritants can have various forms , including mechanical , 
thermal , chemical and biological and can range in severity from a slap on the wrist to a 
life-threatening infection . An acute inflammation can be abrupt in onset and last only a 
short time. A chronic inflammation can result from long-standing acute inflammation. 
The onset of irritation causes several changes within the host: redness , heat and 
swelling are the most common at the site of irritation . These changes affect the 
vasculature of the area and cause the vessels to vasodilate , allowing fluids , proteins , and 
inflammatory cells to have access to the area [1]. The inflammatory cells are able to 
reach the site of the irritant through a complex array of chemical mediators that 
chemotactically attract them to the area by encountering a complex system of 
intracellular and extracellular adhesion molecules and cytokines [2]. The inflammatory 
cells attracted to the area , specifically the polymorphonuclear cells (PMNs) are the 
primary subjects of this investigation . The PMNs are the first leukocytes to encounter the 
irritant and to try to rid the host of any foreign body. PMNs are extremely effective at 
destroying the irritating bacteria they encounter through a number of mechanisms such as 
phagocytosis and the release of lysozymes. However , this destruction may not be limited 
to bacteria that caused the inflammatory response. Often healthy host tissues are injured 
in the process of destroying bacteria [3, 4] . 
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Lesions of Endodontic Origin 
The inability of the inflammatory cells to limit their destructive mechanisms to 
the bacteria leads to host tissue destruction . In the case of endodontic disease, bacteria 
invade the pulp and initiate the inflammatory response [ 5]. The inflammatory response in 
and around the pulp leads to destruction of the local tissues that create lesions of 
endodontic origin [ 6-11]. The bacteria present in the pulp canal space release host factors 
such as chemokines and cytokines that attract inflammatory cells to the area. The 
cytokines cause activation and chemotaxis of the inflammatory cells in the site. When 
the inflammatory response becomes disproportionate to the inflammatory condition , the 
result is bone resorption , granulation tissue , and, finally, endodontic lesion [9, 12-16]. 
The term lesions of endodontic origin refers to the chronic inflammatory response and 
tissue destruction associated with the pulp of the teeth having persistent bacteria present 
which infect the surrounding periradicular tissues with bacterial toxins , enzymes, and 
waste products [ 1 7]. The presence of endotoxin in this tissue was found in this 
investigation to be a major contributor to the breakdown of the host tissues [18-20]. 
Bacteria Associated with Lesions of Endodontic Origin 
Bacteria have been associated with periradicular pathosis for over a century. 
Normally the pulp is surrounded by dentin , enamel, and cementum that protect the pulp 
from physical , thermal and chemical injury. However, when these protective agents are 
lost or destroyed , the pulp becomes vulnerable to outside bacteria [5]. The need for 
bacteria in the formation of lesions of endodontic origin was first demonstrated by 
Kakehashi et al. in 1965 [21]. Pulp of conventional and gnotobiotic , germ-free rats were 
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mechanically exposed and left open . The conventional rats developed lesions of 
endodontic origin while the gnotobiotic rats did not. This work has since been supported 
by numerous studies illustrating the critical role that bacteria play in lesions of 
endodontic origin [6, 7, 12, 20 , 22-24]. 
The types of bacteria associated with infected root canal systems are numerous 
and vary from aerobic to anaerobic , Gram ( +) to Gram (-). Current culturing techniques 
and research have indicated that up to 90% of the bacteria associated with infected root 
canal systems are anaerobic [6, 7, 12, 25-27]. Spirochetes have also been isolated from 
infected root canal systems [28]. Table 1 lists the bacteria commonly associated with the 
infected root canal system [6, 7, 12, 24 , 26, 29-37]. 
The time and quantity of bacteria present in an endodontic system directly relate 
to the severity of the pulp and periradicular inflammation [38]. This study by Korzen et 
al. demonstrates that the longer the pulp is exposed to the various bacteria and the more 
bacteria that are present , the more severe the reaction will be. It was also found that 
mixed infections produced a more severe inflammatory response than monoinfections. 
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Table 1: 
Bacteria Commonly Associated with Infected Root Canal Systems 
Anaerobic 
Gram(+) cocci 
Peptococcus 
Peptostreptococcus 
Gram(-) cocci 
Veil/one/la 
Gram ( +) bacilli 
Actinomyces 
Eubacterium 
Lactobacillus 
Gram(-) bacilli 
Porphyromonas 
assacchrolyticus 
endodontalis 
gingivalis 
Prevotella 
intermedia 
melaninogenica 
nigrescens 
tannerae 
Facultative Anaerobes 
Gram(+) cocci 
Staphylococcus 
Streptococcus 
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Porphyromonas gingivalis 
P orphy romonas ( once known as Bacteroides) gingivalis is a Gram (-) non-motile 
short rod and among the most commonly studied anaerobic bacterial pathogens of the 
oral cavity . P. gingivalis can be isolated from the gingival sulcus , buccal mucosa , 
tongue, infected root canal systems, and virtually throughout the oral cavity. The black 
pigmentation of P. gingivalis is from the hemin, which is accumulated within the bacteria 
and used as an iron source during its development. It has been shown that iron is an 
important regulatory signal in many organisms and that the virulence of P. gingivalis can 
be increased by a reduced amount ofhemin present in the bacteria [39, 40]. Fimbriae can 
be found along the cell surface of P. gingivalis , which allow the bacteria to adhere to 
hydroxyapetite and to human oral epithelial cells. The ability of the fimbriae to adhere to 
periodontal tissues is an important aspect of the bacteria ' s virulent role in the oral cavity 
[ 41, 42]. P. gingivalis is significant in its association with acute apical abscesses and the 
purulent discharge from this type of infection due to the bacteria ' s highly virulent nature 
[35]. 
Lipopolysaccharide (LPS) is a component of bacterial endotoxin in cell walls of 
Gram (-) bacteria such as P. gingivalis. It serves as one of the major virulence factors in 
increasing the inflammatory response [ 43-45]. LPS is a glycolipid composed of two 
structurally distinct regions: a hydrophylic polysaccharide region and a hydrophobic 
domain , commonly called lipid A The variations in the carbohydrate structure of the 
LPS yield different properties to different bacteria [ 46]. Most LPS-induced host response 
reactions are due to the highly conserved lipid A portion of the glycolipid. Lipid A is 
composed of six fatty acid residues linked to a diglusamine headgroup. Leukocytes in 
15 
essentially all multicellular organisms recognize LPS and have multiple receptors for the 
LPS protein complex [ 4 7]. 
Porphyromonas gingivalis in Lesions of Endodontic Origin 
Bacterial infections of the dental pulp result in pulp al destruction that initiates an 
inflammatory response. The unbalanced inflammatory response results in destruction of 
surrounding bone and formation of granulation tissue. The components of bacteria such 
as P. gingivalis induce the production of polypeptide mediators such as chemokines and 
cytokines from the inflammatory cells. P. gingivalis originates in the oral cavity and 
infects the root canal system through mechanical exposure , carious lesion and other 
means of communication. The components of P. gingivalis in the root canal system 
stimulate the inflammatory cells to recruit more inflammatory cells to the area. These 
inflammatory cells attempt to rid the root canal system and surrounding periradicular area 
of the bacterial components. This process not only destroys the bacteria but also destroys 
the surrounding bone and soft tissue resulting in a cascade of events , including the 
complement system, the production of prostaglandins , etc. Therefore , the process is 
constantly changing and the root canal system environment is in a constant state of flux 
[1, 3, 4, 14, 48 , 49]. 
Porphyromonas gingivalis in Periodontal Disease 
P. gingivalis acts in a very similar manner in periodontal disease as it does for 
lesions of endodontic origin. The components of P. gingivalis , that elicit the host 
response in lesions of endodontic origin , are the same in periodontal disease and elicit the 
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same cascade of events . The cycle of inflammatory cells being recruited to the area 
ultimately leads to bone loss and soft tissue destruction of the periodontal region . The 
cycle of bone loss and regeneration is in a constant state of remodeling. Evidence 
indicates that the constant change is due to the variation in the bacterial environment at 
any given time [ 10, 28]. The mixed bacterial environment is believed to be far more 
destructive to the surrounding tissues as the bacteria work in a symbiotic manner [50]. 
Human Diabetes 
A classification for diabetes and other forms of glucose intolerance was devised in 
1979 by an international workgroup sponsored by the National Diabetes Data Group; the 
World Health Organization endorsed this classification system in 1980. Diabetes 
mellitus was recognized as a syndrome , a collection of disorders , that have 
hyperglycemia and glucose intolerance as its main characteristics due to insulin 
deficiency, impaired effectiveness of insulin ' s action, or a combination of both. 
Common symptoms of diabetes are polyuria , polydipsia , and other acute problems of 
hyperglycemia. Furthermore , diabetes was subclassified as insulin-dependent diabetes 
mellitus (IDDM or Type I) and non-insulin-dependent diabetes mellitus (NIDDM or 
Type II) [51-54]. 
Diabetes: Type I 
Type I diabetes is caused by destruction of the ~ cells in the pancreas , which leads 
to almost total loss of insulin secretion and absolute insulin deficiency. This type of 
diabetes accounts for about 5-10% of all diabetics. The destruction of the ~ cells is either 
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autoimmune or idiopathic . The autoimmune cases have varying rates of p cell destruction 
and have markers such as antibodies to the islet cells, and insulin . It is believed that type 
I diabetes can be inherited as part of the major histocompatibility complex on 
chromosome 6. This form can therefore be detected before clinical detection due to the 
autoantibody markers. However , it rarely is detected until clinical symptoms become 
apparent , such as thirst , polyuria , and weight loss [55-58]. 
Type I diabetes is generally juvenile in onset and must be treated throughout the 
remainder of the patient's life. Treatment typically consists of attempting to mimic the 
physiologic insulin levels , which rise and fall throughout the course of the day. Normally 
insulin levels are low during the fasting state and increase during a meal due to increased 
blood glucose levels. When the blood glucose level declines after the meal the insulin 
level also declines and hypoglycemia is avoided. The constant fluctuation of the blood 
glucose levels and insulin levels are in a delicate balance in the healthy individual and is 
the reason insulin injections can be so problematic for accurately controlling diabetes [51, 
58-60]. 
Diabetes: Type II 
Type II diabetes generally occurs during middle age and accounts for 
approximately 90-95% of all diabetics in the United States. Type II diabetics typically 
develop a resistance to insulin in peripheral tissues and about a 50% reduction in the 
number of P cells. It has been found that there is a genetic component to type II, 
however , the specific genes are not known. The non-genetic factors involved in this 
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include aging, weight gain , hypertension , etc. This form of diabetes often goes 
undetected for years due to lack of symptoms [52-54, 61]. 
There are several diagnostic criteria for type II diabetes such as: fasting plasma 
glucose at or above 125 mg/dL, symptoms of diabetes and casual plasma glucose at or 
above 200 mg/ dL. The symptoms of diabetes can often take up to ten years before 
becoming apparent. This is a problem because after ten years of hyperglycemia 
microvascular changes have occurred. It is often microvascular changes that develop into 
premature macrovascular disease , nonproliferative retinopathy , and early nephropathy . 
For this reason, it is recommended that patients over 45 be tested every 3 years for fasting 
plasma glucose levels and even younger if they fall into a high risk category, such as 
obesity, hypertension , etc [51, 54]. 
The Streptozotocin Model of Diabetes 
The most consistent finding with type I diabetes is the substantial decrease in the 
number of insulin secreting p cells. Studies have shown that xenobiotics such as 
streptozotocin (STZ), a naturally occurring antibiotic product of Streptomyces 
achromogenes , can be used to induce p cell destruction through triggering an 
autoimmune response directed towards the P cells [62-64]. STZ is a nitrosourea that can 
enter the p cell and spontaneously decompose. It is believed that this action can have 
lasting effects on the DNA of cells leading to their destruction in genetically susceptible 
specimens. It was also noted that a C type retrovirus was present in these islet cells. STZ 
labeled with 14C has been used to illustrate that the STZ selectively alkylates key proteins 
in the p cells [63]. 
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Like and Rossini developed the multiple low-dose STZ injection model to study 
diabetes that most researchers use today. There are two spontaneously occurring genetic 
models also used today , BB rat and NOD mouse. Doses of 40 mg per kg of body weight 
of STZ were administered once daily for five consecutive days to eight-week-old outbred 
CD-1 male mice. It was found that males were more susceptible to STZ injections and 
that it required approximately 7 days to develop a severe glucose intolerance [62, 65]. 
The third component of the effectiveness of the multiple low-dose STZ injection 
model is the host thymic response playing a critical role in releasing autoimmune T-
lymphocytes. Autoimmune T-lymphocytes are specifically directed at the p cells and 
play a crucial role in their destruction. Paik et al. were able to confirm Like and 
Rossini ' s work that illustrates the third component of p cell destruction with the multiple 
low-dose injections of STZ [66, 67]. Thus, STZ has a triad effect on the p cell 
destruction: first the direct cytotoxicity of the STZ, second the C type retrovirus that is 
induced within the P cell, and third the cell mediated autoimmune reaction [ 68]. 
The relatively selective ability of the multiple STZ injection method makes it a 
relatively good model for the study of type I diabetes. The animal model of diabetes has 
many obvious advantages that the human model cannot provide. The fact that animals 
can be genetically altered and bred for specific genotypes , that they can be sacrificed and 
biopsies performed , and that new medicaments can be readily tested, are among the many 
advantages afforded through animal models of human ailments [ 69-73]. 
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Complications of Diabetes 
Type II diabetes is increasing in the developing countries where urbanization of 
once rural areas is changing the lifestyle and eating habits of the population . The fact 
that people are living longer contributes to the growing number of cases because type II 
incidence increases with age. The Hispanic , Native American and African American 
populations have been among the most affected in the United States [51, 54]. 
Patients with diabetes have "a group of metabolic diseases characterized by 
hyperglycemia , with disturbances of carbohydrate , fat, and protein metabolism resulting 
from defects in insulin secretion , insulin action, or both" [7 4]. Chronic hyperglycemia 
leads to the microvascular changes responsible for the majority of symptoms seen in the 
diabetic patient. The hyperglycemic state exhausts the ~ cells, because they are 
constantly required to produce insulin to keep glucose level down. There are three things 
that the chronic hyperglycemic state brings about. First , the excess glucose reacts with 
lysine residues of protein , a condition known as glycosylation. This is transformed to an 
Amadori product , which is irreversible . The Amadori products can become incorporated 
with other proteins to generate advanced glycation end products (AGE). AGE can lead to 
endothelial dysfunction and stimulate phagocytes to release inflammatory cytokines such 
as TNF a and IL-6. Secondly, excess glucose is also turned into the alcohol, sorbitol 
through the aldose reductase pathway. This increases the ratio of oxidized pyridine 
nucleotide (NAD) and decreases the activity of the glutation redox cycle, one of the main 
antioxidant mechanisms. Third , hyperglycemia is also believed to increase the 
diacylglycerol and protein kinase C (PKC) pathway. Activated PKC may affect vascular 
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permeability , contractility , basement membrane turnover , adhesion molecule expression, 
cell growth, and regulation of coagulation and fibrinolysis [51]. 
The long-term hyperglycemic state has lasting effects on the body. The three 
situations mentioned above affect the microvasculature of the individual and can 
ultimately affect the macrovasculature , as well as organ systems throughout the body. 
The microvascular changes mentioned above generally lead to retinopathy , nephropathy , 
and can also lead to neuropathy. It is generally these three changes that cause the 
characteristic complications associated with diabetics patients: loss of feeling in certain 
extremities , poor circulation , blindness , coronary heart disease, etc. [51-53, 59, 60, 73-
75]. The following sections will examine some of the specific complications of the 
diabetic patient. 
Periodontal Complications of Diabetes 
Periodontal disease often coexists with diabetes and each is believed to 
complicate the other. Grossi and Genco found that severe periodontal disease increased 
the severity of diabetes . The infection found in active periodontal disease has chronic 
LPS present which is believed to upregulate the inflammatory cytokine production in the 
periodontal area. The increased inflammatory cytokine levels seem to increase the 
magnitude of the AGE mediated cytokine response. Not only does the chronic LPS in the 
area upregulate inflammatory cytokine production , but the AGE does also. This action 
would be useful in explaining the severe amount of tissue destruction that is often 
associated with periodontal disease in diabetics [76]. Lalla et al. support that AGE is a 
destructive component in periodontal disease in diabetics because they were able to 
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successfully block the receptor for advanced glycation end products (RAGE) and show a 
decrease in the amount of alveolar bone loss [77]. 
Nishimura et al. examined the effect of AGE on inflammatory cytokine levels and 
found that TNF a levels were indeed elevated in the hyperglycemic state. They extended 
their examination to the periodontal ligament cells (PDL) and found that their adhesion 
and motility were impaired when grown in a hyperglycemic environment. Conversely , 
cells grown in a hypoglycemic environment gradually dissociated from their anchor and 
underwent cell death. These changes in glucose levels had a more dramatic effect on 
PDL cells than on fibroblast [78, 79]. Manouchehr-Pour et al. determined that diabetics 
did indeed have a lower PMN chemotactic response than non-diabetics with periodontal 
disease [80]. Iacopino explains the altered macrophage phenotype and chemotaxis by 
pointing out the hyperlipidemia , which is often present in diabetics , may lead to direct 
fatty acid interactions with neutrophil and macrophage cell membranes that could 
interfere with the membrane-bound receptors and enzyme systems [81]. Smud and 
Sermukslis were able to administer drugs to lower the serum low-density lipoprotein and 
triglyceride levels which also reduced the severity of some typical diabetic complications 
[82]. 
Cardiovascular Complications of Diabetes 
The majority of deaths among the diabetic population occur as a result of 
cardiovascular dysfunction . Experimental models have shown slower rates of pressure 
generation , lower maximal pressure rates , elevated diastolic levels, attenuated cardiac 
work and cardiac output. Excessive lipid and glycogen deposits are often found within 
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the heart and abnormalities are seen in the Ca2+ associated functions of the mitochondria . 
It is believed that insulin deficient hearts are more susceptible to ischemic injury. The 
chronic transient states of hyperglycemia and insulinemia are also seen to be associated 
with vascular damage and dysfunction [83]. 
Many of the microvascular and macrovascular problems of the diabetic have been 
related to the accelerated formation of AGE. Rumble et al. examined the role of AGE in 
vascular disease and found that AGE was, in fact, present in higher quantities in the 
diabetic and that there were pathologic changes. When aminoguanidine was used to 
inhibit AGE formation in diabetics , there were significantly fewer vascular pathologic 
changes [84]. W autier et al. focused on endothelial cell dysfunction as one of the 
primary vascular challenges as it increases vascular permeability and thrombogenicity. 
AGE appears to be the major component that impairs endothelial cell function when it is 
bound to RAGE on the endothelial cell. The blockade of RAGE was shown to inhibit the 
diabetes-mediated hyperpermeability of endothelial cells [85]. 
Peripheral Limb Infections of Diabetes 
Foot problems are a major cause of hospitalization among diabetic patients . In 
fact, 20% percent of all diabetic patients will be hospitalized sometime during their life 
with a foot problem. Typically , the patient presents lesions resulting from peripheral 
neuropathy , autonomic neuropathy , and peripheral vascular disease. These cases often 
become infected and these infections have been shown to play a role in as many as 68% 
of these extremity amputations . Motor neuropathy often leads to atrophy of the muscles 
in the area and the problem begins as a foot ulcer with an infection where irregular wear 
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exists. The individual generally also experiences joint stiffness due to collagen 
glycosation , which makes them unable to redistribute the weight of their body. The 
vasculature of the area is also compromised as a result of macrovascular disease , 
resulting in impaired blood flow to the area that affects the nutrients that have access to 
the injury , and slowing healing even further [86, 87]. 
The immune system of diabetic individuals is often questioned , as it is commonly 
believed that phagocytic activity may be altered. Liu et al. showed that AGE does reduce 
macrophage phagocytic activity [88]. Doxey et al. demonstrated that diabetic rats had a 
generalized reduction in their cytokine release. They later demonstrated that 
hyperlipidemic non-diabetic rats had cytokine levels similar to diabetics. Taken together 
their findings support the hypothesis that elevated serum lipids are the primary reason for 
reduced macrophage cytokine release [89]. However , studies by Salvi et al. 
demonstrated a higher level of cytokine release in response to LPS [90]. Loffreda et al. 
investigated the role of leptin levels in diabetic complications. Leptin is known to 
regulate the appetite and the lack of leptin results in hyperphagia , decreased energy 
expenditure , and obesity. Rodent models with genetic abnormalities in leptin or leptin 
receptors show marked deficits in macrophage phagocytosis and the production of 
proinflammatory cytokines. These deficits were reversible when exogenous leptin was 
introduced into the rodents ' system [91]. 
Bone Metabolism Complications of Diabetes 
Bone metabolism of type I diabetic individuals is drastically reduced when 
compared to non-diabetics. Type I diabetics typically show a 10% reduced bone mass 
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when measured by X-ray radiogrammetry. The incidence of bone fracture in diabetics is 
approximately twice that of non-diabetics. Diabetics have abnormalities in calcium 
absorption and excretion resulting in hypercalciuria . Abnormalities in vitamin-D 
metabolism have been noted in diabetic individuals [92]. Verhaeghe et al. found urinary 
calcium excretion to be increased more than ten-fold and serum concentrations of la , 25-
dihydroxyvitamin D3 and vitamin D-binding protein to be significantly decreased in 
diabetic rats. Daily bone formation was found to be 86% less in diabetic rats. Similarly , 
the serum concentration level of osteocalcin , a marker of osteoblast function , was also 
reduced. These factors result in decreased bone strength of rat femurs [93, 94]. 
Macey et al. tested the tensile strength of previously fractured femora from 
diabetic and non-diabetic rats. Diabetic rats receiving insulin treatment had similar 
tensile strength and stiffness to that of non-diabetic rats while untreated diabetic rats had 
severely reduced tensile strength and stiffness . The collagen content of the untreated 
diabetic rats was significantly lower than that of the other two groups between the fourth 
and eleventh days of healing [95]. 
Skin Complications of Diabetes 
Skin manifestations in the diabetic patient are common. It has been shown that 
collagen production in diabetic individuals is impaired [96] . There are several skin 
disorders that diabetics are more susceptible to than non-diabetics , however they are not 
exclusive to the diabetic . Necrobiosis lipoidica diabeticorum is rare even among 
diabetics. It typically presents as scaly erythematous papules in the pretibial area. These 
papules generally coalesce into larger plaques with a thin atrophic epidermis having 
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superficial and deep diffuse dermal granulomas. The dermal changes feature 
degenerative collagen associated with an absence of elastic tissue. The yellow color of 
these lesions is believed to be from adipose tissue deposited in the area [97]. 
Diabetic skin spots are seen in 70% of diabetic men over the age of 60. 
Pigmented pretibial papules are the most common form of lesion, which begin as pink 
patches approximately 1 cm in diameter. The lesions evolve into brown hyperpigmented 
regions exhibiting surface atrophy and a fine scaly appearance. The incidence of 
cutaneous infections of these sites is an issue of concern that must be investigated in 
terms of impaired microcirculation , hypohidrosis , and suppressed cell-mediated 
immunity of diabetics. Diabetics are most commonly infected with Staphylococcus 
aureus as they are exposed through the open lesions and bullae the diabetic have on their 
extremities. These bullous lesions can often become infected and lead to diabetic 
gangrene [97] . 
Wound Healing Complications of Diabetes 
There is interesting evidence to suggest that diabetics have several variables 
involved in their complicated recovery from infections. Diabetic patients have been 
shown to have higher carrier rates for Staphylococci on the skin and Candida on the oral 
and genital mucosa [98]. This increased exposure to these pathogens will also increase 
the risk of infection. Infection causes elevated blood sugar levels, which further 
complicate healing because the increased blood sugar can attach itself to the thioester 
bond of C3 from the complement system. Covalent attachment of C3 to the microbial 
surface is critical for phagocytic recognition . Excessive glucose in the blood can bond 
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with this C3 and make microbial phagocytosis very difficult , allowing microbial growth 
to continue [99]. 
Microbial rates of Staphylococcus aureus have been found to be higher in diabetic 
patients than in non-diabetics . This pathogen was responsible for 57% of bacteremia ' s of 
unknown origin and 30% of infections in the extremeties [100]. Urinary tract infections 
were found to have a higher percentage caused by Klebsiella in the diabetic 24% 
compared to the non-diabetic 13% [6, 101, 102]. 
Diabetes Relating to Lesions of Endodontic Origin 
Uncontrolled diabetes can play a critical role in the healing or non-healing of a 
lesion of endodontic origin. Kohsaka et al. histologically and histometrically evaluated 
the changes in pulp periapical tissues of control and diabetic rats that had mechanically 
induced pulp exposures. They found the diabetics to have more severe inflammation in 
the apical periodontal ligament , root resorption and alveolar bone resorption when 
compared to the control rats. They also were able to see significantly larger lesions in the 
periapical area of the diabetic rats when compared to the control rats [ 103]. These results 
are expected as we have seen the difficulty uncontrolled diabetics have chemotactically 
attracting inflammatory cells to an area of infection. This also results in increased 
destruction of the surrounding tissues , and delayed healing times due to impaired bone 
and soft tissue reconstruction [93]. 
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Materials and Methods 
Experimental Animals 
A total of 105 CD-1 mice were obtained from Jackson Laboratories (Bay Harbor , 
ME). There were two experimental groups: 1) 53 control mice were 10 weeks old on 
arrival; 2) 52 diabetic mice were injected with STZ (Fisher Scientific , Hanover Park , IL) 
at 8 weeks of age to destroy the ~ cells of the pancreas and induce diabetes about two 
weeks after the STZ injections were initiated. 
Creating Diabetic Mice 
The mice were weighed to determine the amount of STZ injections that they would 
require to induce diabetes. The mice also had their pre-injection blood sugar levels 
measured via a tail bleed . The 0.01 M citrate buffer (pH 4.5) was prepared using sodium 
citrate mix (Fisher Scientific , Hanover Park , IL) and mixing 2.94 mg/1 of distilled water 
and the pH was adjusted to 4.5 by adding HCL The final solution was sterilized and 
prepared fresh every time injections were given. The STZ injection solution was 
prepared by mixing 30 mg of STZ in 7.5 ml of the citrate buffer. The STZ solution was 
filtered with a 0.2 mm filter . The mice received 10 µ1/g body weight by intraperitoneal 
injection. The injection of STZ solution was repeated once a day for five days. The 
blood sugar was checked twice a week with a target blood sugar of 250-300 mg/dl. The 
mice became diabetic within eight to sixteen days of the initial STZ injection and were 
required to remain diabetic for eight days prior to the calvarial injection. 
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Porphyromonas gingivalis, strain 381 
The vial of frozen P. gingivalis strain 381, ATCC 33277 (American Type Culture 
Collection , Rockville , MD) was removed from the -20°C freezer and allowed to thaw for 
10-15 minutes. A streaking loop was dipped in the alcohol and passed through the flame 
of a Bunsen burner. The loop was allowed to cool near the flame to avoid potential 
contamination. A pipette was used to transfer 50 µl of the stock P. gingivalis onto a 
blood agar plate , commercially formulated complex medium, TSBY trypticase soy agar 
and brain , heart infusion agar with yeast extract plus hemin and vitamin K (Northeast 
Laboratories , Winslow, ME). The loop was placed into the bacteria on the plate and the 
plate was streaked in thirds. Between streaking each third of the plate, the loop was 
passed through the flame. As the loop was placed back on the plate to streak the next 
third only one pass was made through the previous third . This procedure was followed so 
that each third would be less concentrated. Breathing or talking near the plate did not 
occur during plating. Once the plate was completely streaked , it was placed in an 
anaerobic chamber with one pack of Gas Pak Plus (Becton Dickinson , Sparks, MD), 
which required 10 ml of water, and was sealed creating an anaerobic atmosphere of 10% 
CO2, 10% H2, and 80% N2. This was stored at 3 7°C for 5-7 days. At the end of 5-7 days, 
the chamber was removed from the 3 7°C room and opened in order to provide bacteria to 
be re-streaked from one single colony, per plate , for use in the experiment the following 
week. The new plates were re-streaked and the chamber sealed once again, while the old 
plates were kept in the event of contamination of one of the plates. After 5-7 days, the 
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new plates were removed and the bacteria harvested for injection while they were in early 
to middle log phase growth. 
The bacteria were harvested from the plates and each plate of bacteria was placed 
into a I ml vial of sterile endotoxin-free lxPBS. The stock solution had 500 µl removed 
and this portion was diluted for measuring in the spectrophotometer (560 nm). The 
optical density (OD) reading was then used to determine the amount of bacteria present 
based on a standard curve established by colony formation on bacterial plates. When a 
solution with 5xl 08 /ml of bacteria was created the mice were prepared for injection with 
the various solutions. 
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Table 2: Standard Curve for Porphyromonas gingivalis 
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Injection of CD-1 Mice with Various Solutions 
The mice were anesthetized with intraperitoneal injections of 100-120 µ1 of 
anesthesia solution consisting of 1 ml of ketamine (100 mg/ml) and 1 ml of xylazine (20 
mg/ml) (Rompum , Columbus , OH) and 6 ml of sterile phosphate-buffered saline (lxPBS) 
solution (Ketaset , Fort Dodge , IA). Once the mice were anesthetized their heads were 
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shaved at the site of the calvarial injection. They were then injected with 50 µl of the 
desired solution: fimbriae of 1 µg/µl concentration , LPS of 1 µg/µl concentration , live P. 
gingivalis of 5x108/ml concentration , Saline of lxPBS. The injection site was adjacent to 
the periosteum between the ears at the area of the coronal suture in the midline of the 
calvaria. 
Table 3: Number of specimens in each group 
Diabetic (52) Normal (53) 
Fimbriae LPS Saline Live P.g. Fimbriae LPS Saline Live P.g.. 
1-Day 1 8 8 9 1 8 8 
3-Day 0 9 8 9 0 8 8 
Four hours after the calvarial injections the mice received 300 µl of crystiben 
antibiotic , injected subcutaneously on their backs. 
Preparation of the Specimens 
The mice were sacrificed at the designated time points, by CO2 inhalation for 30 
seconds. They were subsequently decapitated and their nose and mandible were removed 
from their heads for better fixation. The remaining portion of the head was placed in 4% 
paraformaldehyde for 48 h for the 1-day study, and 72 h for the 3-day study. They were 
stored in a cold room at 4°C. The heads were removed from the paraformaldehyde 
solution and dissected further to leave only the calvaria and contacting scalp intact. This 
portion of the head was placed in gauze and then in a Histo-prep capsule. The heads with 
the capsules were then washed on a stirrer in the cooler room at 4°C: 15 min in 5% 
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glycerin, then 15 min in 10% glycerin , and finally 15 min in 15% glycerin . The heads 
with the capsules were then placed in immunocal (Decal Corporation , Congers , NY) for 
three days on the stirrer in the cooler room at 4°C. After three days of decalcification , the 
heads with the capsules were placed in Cal-Arrest (Decal Corporation , Congers , NY) for 
20 min on the stirrer in the cooler room at 4°C. The Cal-Arrest was replaced and this step 
repeated. The specimens were then placed with the capsules in 30% sucrose for 24 hon 
the stirrer in the cooler room at 4°C. This procedure was used to dehydrate the specimens 
so the cells would not rupture when frozen. The remainder of the calvaria and skin were 
dissected away from the specimen and it was placed in precooled methylbutane at -80°C. 
The calvaria were preserved in the -80°C freezer until sectioning. 
Sectioning of the Specimens 
Each specimen was removed from the freezer and vial of methylbutane , which 
was kept at -80°C, and split in half. One half was mounted in histoprep and frozen at 
-20°C while the other half was placed back in the vial and refrozen at -80°C for future 
use, if required. The specimen that was frozen in the histoprep was sectioned at various 
thicknesses , using a cryostat (Leica, NY). Ten slides of each specimen were collected as 
follows: 1) Standard slide with specimen at 5 µm thickness 
2) Microprobe slide with specimen at 5 µm thickness 
3) Microprobe slide with specimen at 5 µm thickness 
4) Microprobe slide with specimen at 5 µm thickness 
5) Microprobe slide with specimen at 5 µm thickness 
6) Standard slide with specimen at 5 µm thickness 
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7) Microprobe slide with specimen at 6 µm thickness 
8) Microprobe slide with specimen at 6 µm thickness 
9) Standard slide with specimen at 6 µm thickness 
10) Standard slide with specimen at 8 µm thickness. 
The standard slides typically fit 3 specimens and the microprobe slides 
typically fit 2 specimens. The standard slides were used for hematoxylin and 
eosin staining while the microprobe slides were reserved for 
immunohistochemical staining. After sectioning , the slides were either frozen in 
the -80°C freezer or stained and analyzed. 
Hematoxylin & Eosin Staining 
The specimen slides were: 
1) Dipped in hematoxylin for 3 min 
2) Washed in water# 1 for 30 s 
3) Washed in water# 2 for 30 s 
4) Dipped in acid ETOH for 30 s 
(1 ml of 12 M HCl + 99 ml of 75% ethanol) 
5) Dipped in dH2O for 30 s 
6) Dipped in ammonium hydroxide for 30 s 
(200 µl of ammonium hydroxide in 199.8 ml of dH2O) 
7) Dipped in dH2O for 30 s 
8) Dipped in eosin for 3 min 
9) Dipped in 80% ETOH for 3 min 
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10) Dipped in 95% ETOH for 3 min 
11) Dipped in 100% ETOH # 1 for 3 min 
12) Dipped in 100% ETOH #2 for 3 min 
13) Dipped in xylene # 1 for 3 min , under the hood 
14) Dipped in xylene #2 for 3 min, under the hood 
15) Mounted with Permount 
Slide Analysis 
All slides were analyzed under a Nikon light microscope at 40X, 1 00X, and 
1 000X. The slides were analyzed for the center of inflammation at 40X and 1 00X before 
focusing at 1 000X. When the center of inflammation was found the slide was analyzed at 
l000X using 12 fields from the center , six in each direction. The number of PMNs per 
field was recorded and used to determine the amount of inflammation in a given 
specimen. The slides were then examined by a second examiner and the counts verified 
within 5%. 
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Results 
The mice on Day O demonstrated very little if any inflammation in the normal and 
diabetic groups (Figure 1 ). The control mice of this experiment received injections of 
sterile saline (lxPBS) . The normal and diabetic groups responded similarly with minor 
PMN recruitment responses at Day 1 that were quickly resolved at Day 3 (Figure 2) . The 
minor response observed in these specimens may be due to the mild trauma from the 
bolus of injection. 
The normal and diabetic mice receiving injections of P. gingivalis exhibited 
necrotic areas at the site of inoculation on Day 1 (Figures 3 & 4). This was the only 
group to experience necrotic fields on Day 1 (Figure 5). By Day 3, the necrotic cells 
were removed (Figures 6 & 7) and 3.35 PMN/field were noted in the diabetic mice , 
which was 55% greater than in the control mice , 2.17 PMN/field (Table 4 and Figure 8). 
This finding was statistically significant (p<0.05). 
The normal and diabetic mice that received injections with P. gingivalis LPS 
exhibited strong inflammatory responses on Day 1. The most interesting aspect of the 
LPS specimens was in the normal mice reducing the number of PMN s by Day 3 and the 
diabetic mice increasing the number of PMNs on Day 3 (Figure 9). 
The normal and diabetic mice receiving injections of P. gingivalis fimbriae were 
used in an effort to determine the practicality of using this agent as a means of testing the 
host response to the various elements of P. gingivalis. There was only one specimen 
from each group as the supply of fimbriae was too small to continue usage. This small 
sample number makes it impossible to draw any conclusions from the count. 
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Table 4: This table illustrates the number of PMN s counted for each individual specimen and also gives 
the average number of PMNs per group. 
1 Day P.~. Normal PMN/Field 1 Day P.~. Diabetic PMN/Field 3 Day P.g. Normal PMN/Field 3 Day P.g. Diabetic PMN/Field 
PINI Necrotic PlDl Necrotic P3Nl 2.05 P3Dl 5.2 
P1N2 Necrotic P1D2 Necrotic P3N2 2.51 P3D2 3.74 
P1N3 Necrotic 2P1Dl Necrotic P3N3 2.67 2P3Dl 0.62 
2P1Nl Necrotic 2P1D2 Necrotic 2P3Nl 0.96 2P3D2 0.89 
2P1N2 Necrotic 2P1D3 Necrotic 2P3N2 3.85 2P3D3 2.78 
2P1N3 Necrotic 2P1D4 Necrotic 2P3N3 1.84 2P3D4 3.16 
2P1N4 Necrotic 3P1Dl Necrotic 2P3N4 2.37 3P3Dl 6.4 
3P1Nl Necrotic 3P1D2 Necrotic 3P3Nl 0.8 3P3D2 4.21 
3P1N2 Necrotic 3P1D3 Necrotic 3P3N2 2.16 3P3D3 3.15 
3P1N3 Necrotic 3P3N3 2.5 
Ave. of Total for Group Necrotic Necrotic 2.171 3.35 
1 Day LPS Normal PMN/Field 1 Day LPS Diabetic PMN/Field 3 Day LPS Normal PMN/Field 3 Day LPS Diabetic PMN/Field 
LlNl 2.945 LlDl 3.2 L3Nl 1.3 L3Dl 7.3 
L1N2 1.5 L1D2 2.9 L3N2 2.1 L3D2 2.52 
2L1Nl 2.21 2L1Dl 4.42 2L3Nl 2.571 2L3Dl 3.1 
2L1N2 1.7 2L1D2 2.2 2L3N2 1.23 2L3D2 3.7 
2L1N3 1.2 2L1D3 1.44 2L3N3 0.25 2L3D3 4.73 
3L1Nl 1.69 3L1Dl 2.6 3L3Nl 2 2L3D4 3.13 
3L1N2 2.4 3L1D2 1.83 3L3N2 0.625 3L3Dl 5.86 
3L1N3 2.625 3L1D3 2.165 3L3N3 1.524 3L3D2 3.24 
3L3D3 5.2 
Ave. of Total for Group 2.03375 2.594375 1.45 4.308889 
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1 Day Saline Normal PMN/Fjeld 1 Day Saline Diabetic PMN/Field 3 Day Saline Normal PMN/Field 3 Day Saline Diabetic PMN/Field 
SlNl 0.63 SlDl 1.12 S3Nl 0.17 S3Dl 0.705 
SlN2 1.31 2S1Dl 0.89 S3N2 0.125 S3D2 0.1 
2S1Nl 1.67 2SlD2 1.22 2S3Nl 0.09 2S3Dl 0.426 
2S1N2 0.52 2S1D3 1.53 2S3N2 0.25 2S3D2 0.56 
2S1N3 0.7 3S1Dl 1.42 2S3N3 0.21 2S3D3 0.33 
3S1Nl 0.435 3SlD2 1.38 3S3Nl 0.13 3S3Dl 0.33 
3S1N2 1.23 3S1D3 2.88 3S3N2 0.12 3S3D2 0.62 
3SlN3 1.02 3SlD4 1.08 3S3N3 0.11 3S3D3 0.24 
Ave. of Total for Group 0.939375 1.44 0.150625 0.413875 
1 Day Fimbriae Normal PMN/Field 1 Day Fimbriae Diabetic PMN/Field 
2F1Nl 5.02 2F1Dl 0.689 
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Fig. 1 a: Control Fig. 1 b: Diabetic 
Figures la&b: Day O (no injection), little or no inflammation is seen in both control and 
diabetic groups 
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Figure 2: The simple introduction of the saline into the calvaria elicited a minor inflammatory response on day 1 that was quickly 
resolved by day 3. 
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Fig. 3a: Control Fig. 3b: Diabetic 
Figures 3a&b: Day 1, 5Xl 08 of P. gingivalis at the center of inflammation. 
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Fig. 4a: Control Fig. 4b: Diabetic 
Figures 4a&b: Day 1, 5Xl 08 of P. gingivalis at the periphery of inflammation. 
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Figure 5: Day 1 PMN counts from normal and diabetic CD-I mice that were injected with: 
LPS 50 µl of lµg/µl concentration 
Live P. gingivalis 50 µl of 5X108/ml concentration 
Saline 50 µl of IXPBS 
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□ P. g. Normal 
II P.g. Diabetic 
□ LPS Normal 
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Fig. 6a: Control Fig. 6b: Diabetic 
Figures 6a&b: Day 3, 5X108 of P. gingivalis at the center of inflammation. 
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Figures 7a&b: Day 3, 5Xl 08 of P. gingivalis at the periphery of inflammation. 
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Figure 8: At sx108 P. gingivalis concentration , the day 1 groups were necrotic and could not be measured. 
At day 3 the normal group showed greater reduction in inflammation compared to the diabetic group . 
47 
Day 1 Vs Day 3 LPS Injection 
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Figure 9: LPS is a small enough component of P. gingivalis to not exact as strong a response as the P. gingivalis does at day 1, 
yet remain long enough to elicit a stronger response by day 3 in diabetic mice due to the large periphery that the PMN are 
distributed over. 
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Discussion 
Diabetic mice have a greater inflammatory response than normal mice to 
P. gingivalis. This response specifically relates to a more prolonged level of high 
inflammation. Prolonged inflammation is associated with a number of chronic 
inflammatory conditions . The current pathogenic hypothesis behind arteriosclerosis is 
that the disease involves an inflammatory response, autoantibodies , immune complexes, 
cytokine-producing activated I -cells, and bacterial or viral infections responsible for an 
immune response against heat shock proteins [ 104]. One approach for the resolution of 
arteriosclerosis would involve an effort to control the prolonged autoimmune response 
responsible for the inflammation . The theory that arteriosclerosis has an autoimmune 
component that exists over a prolonged time to produce detrimental effects is similar to 
the theories relating to rheumatoid arthritis . Rheumatoid arthritis is a well-known 
autoimmune disease , which deals with prolonged inflammation. There is evidence that 
the immune system in the case of rheumatoid arthritis does not respond appropriately and 
begins to affect the healthy joint tissue in such a manner that leads to long-term 
degenerative defects of the joints. It has been shown that early intervention for both of 
these diseases helps to control and minimize the detrimental effects [104, 105]. The 
effects of these diseases are consistent with the results of this study for showing that 
long-term inflammation has deleterious effects on the body and can best be treated 
through early intervention. 
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Salvi et al. were able to establish a link between periodontal disease and diabetes . 
Their work demonstrated that the monocytes of diabetics were hyper-responsive to LPS 
[90]. The mechanism that became apparent from my study ' s results demonstrated that it 
is not that the initial magnitude of inflammation is greater, but that the inflammation lasts 
longer. This longer lasting result from the LPS can be extremely destructive . The 
activation of matrix metalloproteinases for a longer period of time leads to the breakdown 
of connective tissue and loss of clinical attachment [ 106, 107]. Extended inflammation 
leads to extended production of cytokines that leads to bone resorption. Interleukin- Ip 
(IL-IP) is a potent bone resorptive cytokine that also mediates soft- tissue destruction by 
stimulating prostaglandin production and inducing collagenase and other protease 
activity. Bulut et al. were able to show that IL-IP levels were higher in diabetics than in 
control subjects. These levels were measured directly from the gingival crevicular fluid 
and found to be high in the area of bone loss and soft tissue destruction seen in 
periodontal disease [ 108]. 
It has been well documented that under conditions of severe medical or surgical 
distress patients may become hyperglycemic. These patients are said to have secondary 
diabetes. The severe stress raises plasma concentration levels of glucagons , epinephrine 
and cortisol. The increased level of hormones increases hepatic glucose release, and 
decreases glucose uptake , that results in hyperglycemia. The severe illness also alters 
plasma concentration levels of cytokines that may affect carbohydrate metabolism , 
another critical piece to controlling glucose levels [99]. Interleukin- I (IL-1) with tumor 
necrosis factor (INF) can increase net glucose turnover [109]. The cytokine levels in the 
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diabetic and control mice of this experiment may provide important information for 
explaining why the inflammatory cell responses are altered in the diabetics . 
Fahey et al. studied the levels of leukocytes , TNF and interleukin-6 (IL-6) in 
diabetic mice. The leukocyte numbers and IL-6 levels initially , Days 1 and 3, were 
comparable in diabetics and normal mice. By Day 7 the total number of leukocytes in the 
diabetic areas of infection were significantly lower than the control and the IL-6 levels 
were significantly lower in the diabetics. The TNF levels remained relatively similar 
between the two groups on all the days observed [ 11 O]. These changes in cytokine levels 
could help explain the effects on inflammatory cell numbers evidenced in our study. A 
second phase of this study will utilize RP A studies to evaluate various cytokine levels 
along with the histological data. 
Long-standing inflammation , over a period of time results in the loss of bone seen 
in periodontal disease. It is well documented that the periodontal tissues of diabetic 
patients require particular treatment. The long-term disease of diabetes coupled with the 
long-standing inflammation of periodontal disease has proved to be more than most 
diabetics can deal with , and most diabetics develop some form of periodontal disease. 
Taylor has been able to establish a bi-directional relationship between diabetics and 
periodontal disease. Establishing that one disease can actually effect the other makes it 
especially important to prevent the long-term inflammation and hyperglycemia in an 
effort to control both [111 , 112]. 
It is reasonable to anticipate that the same mechanisms are present in endodontic 
lesions and periodontal disease since P. gingivalis is involved in both. We would expect 
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more prolonged cytokine levels in the endodontic lesions. The prolonged cytokine levels 
would lead us to expect prolonged bone resorption , resulting in larger lesions. 
This study did not measure prolonged cytokine levels. However, a colleague, 
Ghada Naguib , conducting concurrent studies did measure several cytokines levels over 
time. She was able to find that they were expressed at high levels for a longer period of 
time in the diabetic mice. 
Bacteria play a critical role in wound healing. P. gingivalis is one of the critical 
bacteria related to the healing of lesions of endodontic origin since they are generally 
located within infected root canal systems [12, 29, 34]. There are several components to 
P. gingivalis that give it the characteristic make-up and virulence in infections. Two of 
which are thought to stimulate inflammation , lipopolysaccbaride (LPS), and fimbriae. 
LPS is one component that is part of the endotoxin in the cell wall of P. gingivalis [ 16, 
36, 44-46 , 113]. A second component of P. gingivalis is the fimbriae , which actually 
allow the bacteria to adhere to one another and other periodontal tissues [ 114-119]. 
The use of P. gingivalis LPS was based on previous studies indicating the strong 
inflammatory response elicited from this part of the P. gingivalis [43-45, 47, 113, 120, 
121]. Results indicated that the diabetic group experienced an increase from Day lto 
Day 3. This is highly unexpected since all of the other results indicated a reduction in 
inflammation from Day 1 to Day 3. The reasons for this are unknown , however, a second 
independent observer confirmed the results. Wright et al. demonstrated LPS to 
upregulate neutrophil CD 11 b/CD 18 expression in diabetic and non diabetic groups and 
induce a greater than 50-fold increase in the number of neutrophils in diabetic and non-
diabetic groups. The LPS induced a substantially lower change in vascular permeability 
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in the diabetic group [122]. The reduced affect of LPS on vascular permeability in the 
diabetic group could influence wound healing. The similar response our study had on 
Day 1 with the LPS injections was reasonable , based on the similar response seen for the 
injections with P. gingivalis. However, it was unusual that on Day 3 the number of 
inflammatory cells in the diabetic increased from Day 1 in this manner. The system used 
to count inflammatory cells may not have been sensitive enough to distinguish the 
differences in cell numbers for a small, centralized area. 
The method used to count PMN s originated the count from the center of 
inflammation and moved six fields left and right from the center at 1 000X. This method 
covered the area of two to three coronal sutures that included nearly the entire mouse 
calvaria. The inclusion of numbers from such a large area without differentiation as to 
where in relation to the center they originated could have skewed the results . This simply 
made the Day 3 LPS specimens appear to have much greater inflammation than they may 
really have had in relation to the other specimens as their inflammation was spread out 
more evenly over more fields. 
Fimbriae were difficult to obtain and were only used in one specimen per group, 
therefore yielding inadequate numbers to analyze. Because the sample size uses n=l for 
the diabetic and control , we cannot draw any conclusions. However, the fimbriae did 
induce inflammation in both groups. This suggests that P. gingivalis fimbriae can act as 
an inflammatory stimulus in vivo. 
Further work studying which cytokines are present and at what levels in these 
areas of inflammation should be conducted in an attempt to explain the inflammatory cell 
recruitment. Establishing a link between specific cytokines , their levels and 
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inflammatory cell recruitment can prove to be a critical step in studying diabetes and the 
host response to infection. The ability of cytokines to influence vascular permeability , 
and overall recruitment can also prove valuable in understanding the inflammatory 
process of diabetics . A better understanding of how inflammatory cells are being 
recruited to the lesions will help to demonstrate their role in lesion formation and healing. 
The reasons for prolonged inflammation are not known. A study by Lalla et al. suggests 
that Advanced Glycation End products , which occur as a result of hyperglycemia , 
contribute to diabetes-associated periodontal disease [77]. This is significant since 
AGE ' s can act like cytokines and enhance inflammation. 
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Conclusion 
The findings of this study indicated that diabetic mice do indeed have an altered 
inflammatory cell response when compared with normal mice. The injections of P. 
gingivalis in normal and diabetic mice allowed us to study and better understand the host 
ability to recruit inflammatory cells to the site of an infection. The first point taken from 
this work is that diabetic and normal mice initially respond in a similar manner. 
Secondly, we observed that diabetes alters the duration of inflammation that leads to 
prolonged recruitment and activity of PMN. 
Further studies are required to determine how the host response is altered. 
Alterations do occur , yet it remains undetermined if the alterations are due to an altered 
cytokine response or an altered receptor response. Currently, work is being done to 
explore the possibility of an altered cytokine response in the diabetic specimens. 
Preliminary results from work with the cytokines indicate that this approach is promising 
for finding resolution to this long-standing problem. 
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